Stuttgart
22.11.24
08:15 Uhr
3,070 Euro
0,000
0,00 %
0,00 %
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,155 | 3,245 | 11:19 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.10. | HUMANA AB: Humana Appoints Leila Rutanen as Country Manager for Humana in Finland | 1 | Cision News | ||
| 23.10. | Humana AB: Humana reports third quarter and nine-month 2024 results | 85 | GlobeNewswire (Europe) | Continued positive performance developmentSummary of the third quarter
Net revenue was SEK 2,666 million (2,398), an increase of 11 percent.
Organic growth amounted to 1.5 percent (-1.3). Excluding... ► Artikel lesen | |
| 08.10. | HUMANA AB: Invitation to presentation of Humana's report on third quarter 2024 | 2 | Cision News | ||
| 24.09. | The Nomination Committee for Humana AB's 2025 AGM has been constituted | 2 | Cision News | ||
| 24.09. | HUMANA AB: The Government takes into account the conditions for operating personal assistance in the budget proposal | 2 | Cision News | ||
| 21.08. | HUMANA AB: Humana appoints Kimmo Huhtimo as interim Country Manager in Finland | 1 | Cision News | ||
| 13.08. | HUMANA AB: Humana appoints Christoffer Herou as new CFO | 1 | Cision News | ||
| 19.07. | Humana AB: Humana reports second quarter and half-year 2024 results | 229 | GlobeNewswire (Europe) | Significantly improved adjusted operating profit
Summary of the second quarter
Net revenue amounted to SEK 2,534 million (2,410), an increase of 5 percent.
Organic growth was 1.3 percent (2.2).... ► Artikel lesen | |
| HUMANA AB Aktie jetzt für 0€ handeln | |||||
| 09.07. | HUMANA AB: Invitation: Release of Humana's report on the second quarter and half-year 2024 | 1 | Cision News | ||
| 28.06. | Change in number of shares and votes in Humana AB | 1 | Cision News | ||
| 14.06. | HUMANA AB: Humana Assistans AB (";Humana Assistans") takes next step in the damage claim process due to the incorrect decision by the Health and Social Care Inspectorate ("IVO") to revoke Humana Assistans' permit | 2 | Cision News | ||
| 14.06. | HUMANA AB: CFO Fredrik Larsson leaves Humana | 2 | Cision News | ||
| 04.06. | Humana (HUM) Partners With UAB to Boost Care for MA Members | 1 | Zacks | ||
| 03.06. | Humana AB: Humana completes the acquisition of Team Olivia Norge AS | 96 | GlobeNewswire (Europe) | Humana has completed the acquisition of Team Olivia Norge AS. The acquisition is expected to contribute to lower operational risk through a more diversified customer base and broader geographical exposure.
After... ► Artikel lesen | |
| 27.05. | HUMANA AB: Humana announces changes to Group executive management | 1 | Cision News | ||
| 27.05. | HUMANA AB: Humana Assistans AB (";Humana Assistans") applies for damage claim from the state due to the Health and Social Care Inspectorate's ("IVO") erroneous decision to revoke Humana Assistans' permit | 1 | Cision News | ||
| 06.05. | Humana AB: Nathalie Boulas Nilsson appointed new President and CEO of Humana | 282 | GlobeNewswire (Europe) | The Board of Humana has appointed Nathalie Boulas Nilsson as the new President and CEO of Humana AB. Nathalie Boulas Nilsson will also assume the role of Country Manager for the Swedish organisation.... ► Artikel lesen | |
| 25.04. | Humana AB: Humana reports first quarter 2024 results | 184 | GlobeNewswire (Europe) | Diversification creates long-term profitable growth
First quarter, January-March 2024
Net revenue was SEK 2,407 million (2,435), a decrease of 1 percent.
Organic growth was -1.0 percent (5.5)
Operating... ► Artikel lesen | |
| 08.04. | Humana AB: Humana acquires Team Olivia Norge AS | 370 | GlobeNewswire (Europe) | Humana Group ("Humana") strengthens its offering of high-quality care services in Norway as Human Care Holding AS ("Humana Norway") has entered into an agreement to acquire Team Olivia Norge AS ("the... ► Artikel lesen | |
| 08.02. | Humana AB: Humana reports fourth quarter and full year 2023 results | 259 | GlobeNewswire (Europe) | Strong performance from the Group in 2023
Fourth quarter, October-December 2023
Net revenue was SEK 2,396 million (2,438), a decrease of 2 percent.
Organic growth was -2.5 percent (5.5).... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GRAND PHARMACEUTICAL GROUP | 0,505 | -1,94 % | Sirtex Medical Announces Certification of SIR-Spheres Y-90 Resin Microspheres According to Medical Device Regulation (EU) 2017/745 and European Launch of the Innovative SIROS Delivery System | Sirtex brings an innovative liver cancer treatment delivery system to Europe, enhancing options for physicians and their patients.
WOBURN, Mass., Sept. 16, 2024 /PRNewswire/ -- Sirtex... ► Artikel lesen | |
| LNA SANTE | 23,150 | -0,43 % | LNA SANTE: 2024 half-year results | ||
| FRESENIUS | 33,310 | +1,59 % | Fresenius SE Aktie: Erfolgreiche Initiativen stärken Marktstellung! | ||
| SIEMENS HEALTHINEERS | 49,800 | +1,36 % | Siemens Healthineers Aktie: Fortschrittliches Denken zahlt sich aus! | Die Siemens Healthineers-Aktie verzeichnete am Handelstag eine erfreuliche Entwicklung mit einem Kursgewinn von 1,5 Prozent auf 49,86 Euro im XETRA-Handel. Im Tagesverlauf erreichte das Papier sein... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,250 | +1,95 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für FMC von 49 auf 52 Euro angehoben und die Einstufung auf "Buy" belassen. Die Ergebnisse des dritten Quartals seien... ► Artikel lesen | |
| GERRESHEIMER | 73,85 | +4,83 % | Gerresheimer, Lanxess, SMA Solar, ThyssenKrupp, TUI, Wacker Chemie u.a. - Aktien-Positionen der Wacker Chemie | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 55,45 | +1,46 % | Carl Zeiss Meditec Aktie: Am Abgrund? | Die Aktie von Carl Zeiss Meditec erlebte am Freitag einen weiteren Rückschlag an der Börse. Im XETRA-Handel verzeichnete das Papier des Medizintechnikunternehmens deutliche Einbußen und fiel zeitweise... ► Artikel lesen | |
| PROGYNY | 15,440 | +3,17 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| ECKERT & ZIEGLER | 39,880 | +7,84 % | HAUCK AUFHÄUSER INVESTMENT BANKING stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Hauck Aufhäuser Investment Banking hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 55 Euro auf "Buy" belassen. Das Auftragsbuch erscheine vielversprechend... ► Artikel lesen | |
| TEMPUS AI | 58,59 | +11,64 % | Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences | ||
| GENEDX | 78,64 | +9,18 % | GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells $8,973,629.96 in Stock | ||
| PROCEPT BIOROBOTICS | 93,60 | -0,90 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HIMS & HERS HEALTH | 24,240 | -0,37 % | Hims & Hers New Growth Category Is a Huge Surprise | ||
| INTUITIVE SURGICAL | 525,50 | -0,15 % | Intuitive Surgical-Aktie erreicht 52-Wochen-Hoch bei 552 US-Dollar | ||
| TALKSPACE | 3,450 | +4,23 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen |
Das Unternehmen HUMANA AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 3,070 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HUMANA AB finden Sie auf Wallstreet Online.
